Novilytic

Novilytic is a private, pre-revenue biotech tools company targeting the multi-billion-dollar bioanalytical consumables market for large-molecule drug development. Its core innovation, the Proteometer, is a patented, LC-agnostic kit platform that drastically reduces the time, complexity, and cost of protein quality analysis by providing results in minutes instead of days using a customer's existing instrumentation. The company's initial focus is on serving upstream R&D and process development scientists in large pharmaceutical companies, with a commercialization strategy leveraging key partnerships, such as with distributor Avantor, to penetrate the market.

The Proteometer platform: a suite of LC-agnostic consumable kits for rapid, near-real-time analysis of critical quality attributes (titer, aggregates, charge variants) for Fc-containing therapeutic proteins directly from clarified fermentation broth, eliminating Protein A purification and extensive sample prep.

Novilytic primarily competes against traditional, multi-step analytical workflows involving HPLC/UPLC, mass spectrometry, and Protein A purification, dominated by consumable giants like Thermo Fisher, Agilent, and Waters. It may also face future competition from other startups developing rapid, integrated analytical solutions for bioprocessing. Its differentiation lies in speed, simplicity, and direct-from-broth analysis without method development.